Thinking about cognition concepts, targets and therapeutics
100 Years after the discovery of Alzheimer's disease, neurological diseases and psychiatric disorders represent the largest and fastest growing unmet medical market with 2 billion affected people worldwide. Life expectancy of humans continues to increase, and the world population is aging. Adva...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Washington, DC :
IOS Press
c2006.
|
| Edición: | 1st ed |
| Colección: | Solvay Pharmaceuticals Conferences ;
v. 5. |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009798135406719 |
Tabla de Contenidos:
- Title page; Preface; List of Contributors; Contents; Conference Preface; Keynote Lecture - The Meaning of Cognition in our Society and Health Care Systems; Age-Associated Memory Impairment; Cognition in Alzheimer's Disease and Related Disorders; Cognitive Deficits as a Core Feature of Schizophrenia; Cognition in Depression and Mania; Linking Pre-Clinical and Clinical Approaches to Therapy for Cognitive Dysfunction in Neuropsychiatric and Neurodegenerative Disorders; Pre-Clinical Models of Cognition: The Role of the Cannabis Subtype 1 Receptor
- Modulation of N-Methyl-D-Aspartate Receptor Function as a Novel Approach for Development of Antipsychotic AgentsMolecular and Cellular Cognition: Mechanisms of Plasticity; Treatment of Cognitive Deficits: Schizophrenia as an Example; Functional Imaging of Cognition Related Brain Circuitry in Health and in Schizophrenia; Clinical Proof for Cognition Enhancers: Pitfalls and Possibilities; Author Index
